Friday, July 10, 2020 7:14:35 PM
----------------------------------
I have to stress that this is pure speculation - but still 'trying to learn to shape this experience' - I need logic to have some kind of idea of what's going on.
First, why this can only be speculation. One thing I've noticed here on iHub (and other boards for that matter).
Almost all groups of professionals - be they doctors - lawyers - all kinds of biorelate jobs - openly try to hand out to others the 'pro look' in cases.
Only one group of people is completely absent (and I mean 100% absent) is 'Big Money' that controls the Stock Price market setting.
You have never seen (or heard) a GS broker - come out and brag about the millions / billions they earn daily - Ditto people from Oppenheimer - Citi - Hedgefunds. Seems that there is a 'secret code' in these places - that you don't speak 'at all' outside the company walls.
--------------------------
Above as an intro - and I just now need the screen shot I brought here a number of times - from the day after the Du decision. At the time, this curve - locked to $ 4 - looked suspicious. But think I've figured out how to connect the dots in this game.
And what actually triggered me from these speculations is - that ever since the FDA approval in December 2019 - one thing has haunted me:
How could this Leland Gershell guy from Oppenheimer predict the future development of AMRN - so completely accurate?
His take at the time was $ 7 - and sell. Every retailer in AMRN (absolutely including me) hated this man back then - and he was named "every bad character" in the book - for "not understanding" - that Amarin and Vascepa - were on the way to the Stars.
To put it simply - had I taken this man's advice seriously - I could have sold $ 23 (which LG recommended right from the start - against any other analyst out there) - and I could have bought back at $ 4.
Had I followed Leland Gershell's advice, I would have been insanely much better off today (no matter what happens from now on). And, personally, I want to give this guy an official apology - 'should have taken his advice seriously' - instead of just letting emotions rule.
----------------------------------------
The question of Gershell is facts. We all followed what happened to AMRN - he was spot on from the start.
Now the key question is - how could LG know 'the road of AMRN's downfall in advance - and here we come to the speculative guess on my part.
------------------------------------------
Going back to the figure above from Yahoo on March 31, 2020 - I think I have a qualified guess - why it seemed pre-planned to buy the falling stock with a floor of $ 4 (113 million shares the first day after the verdict):
The overall explanation for what is happening is' the persistently large number of trials running all the time - generics trying to move early (e.g. killing patents) as in the case against AMRN.
The explanation of why 'the market just sat there' Ready with a smile '- exploiting the panic among retailers - is quite simple. THEY DO THIS ALL THE TIME - so every time a decision in patents (or other disputes in matters concerning the market) - they have a plan to buy up 'Shares at a steel price' - In case the stock falls like a stone as ANRN surely did.
Back to Gershell '- I would imagine that e.g. the 3 big money tanks - GS - Oppenhimer - City have a shared group of experts who are closely watching these ever rolling lawsuits. Sharks 'ready to' produce billons in a few days - as they certainly did with AMRN.
Probarbly this group - will have close ties to BP - who "suggest" - what price they would like AMRN 'not to go over' before Appeal.
Leland Gershell must have known about this game - noted the political winds - and then taken the approach that Amarin could just as well lose the patent lawsuit. And see what happened SP locked in at $ 7.
--------------------------------------
Emphasizing again - part about how big money - is organized and handling stock buybacks is speculation. The hope is that it can provoke someone with insight to explain some facts - in this billion dollar big money game.
Jasbg
Recent AMRN News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 11:30:10 AM
- Amarin Board of Directors Announces CEO Transition • GlobeNewswire Inc. • 06/04/2024 11:30:00 AM
- Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Greece and Announces Exclusive Marketing and Commercialization Agreement with Vianex S.A. • GlobeNewswire Inc. • 05/28/2024 12:15:23 PM
- Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference • GlobeNewswire Inc. • 05/06/2024 12:00:00 PM
- Amarin Reports First Quarter 2024 Business Update and Financial Results • GlobeNewswire Inc. • 05/01/2024 11:00:00 AM
- Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event • GlobeNewswire Inc. • 04/24/2024 06:00:01 PM
- Amarin Announces Results of Annual General Meeting of Shareholders • GlobeNewswire Inc. • 04/22/2024 12:00:25 PM
- Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024 • GlobeNewswire Inc. • 04/15/2024 12:00:00 PM
- Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24 • GlobeNewswire Inc. • 04/08/2024 12:00:00 PM
- New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • PR Newswire (Canada) • 04/08/2024 10:30:00 AM
- New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • GlobeNewswire Inc. • 04/06/2024 07:30:00 PM
- Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo • GlobeNewswire Inc. • 03/25/2024 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/04/2024 10:30:53 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/04/2024 01:00:24 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 12:06:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 12:05:56 PM
- Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/29/2024 12:00:00 PM
- Amarin to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference on February 29, 2024 • GlobeNewswire Inc. • 02/15/2024 01:00:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/12/2024 01:00:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:31:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:22 PM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM